ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic
and well-tolerated in the pre-clinical toxicity studies, Zydus said.
In the human trials, Zydus will enrol over 1,000 subjects across
multiple clinical study sites in India.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-zydus-begins-human-trials-for-potential-covid-19-vaccine/articleshow/76971798.cms
No comments:
Post a Comment